Sector Alpha Week of 2026-09-21
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-21

Seritage Growth Properties

SRG
Real Estate · Real Estate Services

Seritage Growth Properties's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.

The price is between stages. Underneath, the last four quarters read mixed. What settles it: the next one or two quarters of delivery.

Price
$1.9
−54.4% 1Y
Revenue (Mar 26)
$0.0 B
Profit (Mar 26)
$−0.0 B
ROE
−17%
FY25
ROIC
−3.1%
vs WACC 19.0% → −22.1 pp
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Seritage Growth Properties trades at $1.9, between stages. That is −32.1% against its own 200-day average. It sits at 0% of a 52-week range of $2 to $4. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (44 weeks and counting).

Today the stock is between stages. At $1.9 it trades −32.1% versus its 200-day average and sits at 0% of its 52-week range ($2–$4).

Sep 26: $1.9 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 1-year window.
−32.1% versus the 200-day line, week — of stage —
Price50-day avg200-day avg
$4.5$3.8$3.1$2.4$1.7$$2$3Jul 25Oct 25Feb 26May 26Sep 26
$4.5$3.8$3.1$2.4$1.7$$2$3Jul 25Feb 26Sep 26
Beating or trailing, week by week since 2025 Each cell is one week from 2025 to now (63 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jul 25Sep 26

Against the market, two honest reads. Cumulative: over the last 1.2 years the stock moved −39% while the S&P 500 moved +22% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (44 weeks and counting; last ahead the week of 2025-11-14) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

P/E does not price Seritage Growth Properties — earnings are negative, so there is no multiple to rank against its own history. The revenue and margin lines below are where a turn, when it comes, would show first. A P/E returns here the first period the bottom line turns positive.

With earnings negative, P/E does not price — there is no multiple to rank against its own history. The revenue and margin lines below are where the turn, when it comes, will show first.

P/E
earnings negative
PEG
n/m
not derivable — 3-year earnings growth unavailable

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Seritage Growth Properties reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 11 quarters across 2 curves, on partial evidence.

Growth, year by year: revenue +0.0% in FY25 Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoY
6.5%−17%−41%−65%−88%%0%FY21FY23FY25
6.5%−17%−41%−65%−88%%0%FY21FY23FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Where the trailing-twelve-month history is short, the curve falls back to single-quarter year-on-year growth — noisier, and the classifier smooths and caps base-effect spikes before reading. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from
RevenueProfit
−35%−98.8%−53%−99.4%−70%−100.0%−87%−100.6%−105%−101.2%%%−100%−100%Jun 23Sep 24Mar 26
−35%−98.8%−53%−99.4%−70%−100.0%−87%−100.6%−105%−101.2%%%−100%−100%Jun 23Sep 24Mar 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
−11%−13%−16%−18%−21%%−14.4%Jun 23Dec 23Sep 24Jun 25Mar 26
−11%−13%−16%−18%−21%%−14.4%Jun 23Sep 24Mar 26
Revenue growth
Stuck low
latest −100.0% · span −100.0% to −40.0%
ROCE
Stuck low
latest −14.4% · span −20.1%–−11.3%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+0.0%−43.3%
Stock price−54.4%
04 · 4-Factor Sector Score

4-Factor Sector Score

31.0/100 — rank 22 of 27 in Real Estate Services · 51% evidence confidence

Seritage Growth Properties scores 31.0 out of 100 against the 27 companies it is compared with in Real Estate Services, ranking 22. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

The four contributions add to the total exactly: 9.2 + 7.3 + 10 + 4.5 = 31. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Seritage Growth Properties reported $0.0 B of revenue in the Mar 26 quarter. Over 4 years it has compounded at −36.1% a year. The last full year, FY25, came in at $0.0 B. The last four reported quarters add to $0.0 B.

FY25 revenue came in at $0.0 B (+0.0% on the year), capping 4 years at −36.1% compound. The latest quarter (Mar 26) printed $0.0 B, null year on year.

FY25 revenue $0.0 B (+0.0% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
−36.1% a year over 4 years
RevenueYoY growth
0.136.5%0.10−17%0.06−41%0.03−65%0.00−88%$ B%$0B0%FY21FY23FY25
0.136.5%0.10−17%0.06−41%0.03−65%0.00−88%$ B%$0B0%FY21FY23FY25
Mar 26: $0.0 B (null YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
0.011−46%0.008−61%0.005−75%0.003−90%0.000−104%$ B%$0B−100%Jun 23Sep 24Mar 26
0.011−46%0.008−61%0.005−75%0.003−90%0.000−104%$ B%$0B−100%Jun 23Sep 24Mar 26
06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

A clean operating margin is not in our numbers for Seritage Growth Properties — its accounts do not report the operating-profit line this section reads, which is common for lenders and holding companies. The sections above and below carry the readings this company's filings do support.

This company's accounts do not report the operating-profit line this section reads — common for lenders and holding companies classified outside the financial bucket. The revenue and net-profit sections are the cleaner reads for Seritage Growth Properties.

Why the margin moved: operating margin went +0.0 pp year on year while gross margin went −50.0 pp — the gain came mostly from the gross line: input costs and pricing.

FY25: −300.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
within a −850.0–−125.0% band over 5 years
operating marginYoY change (pp)
−67%485%−277%178%−488%−130%−698%−437%−908%−744%%%−300%400%FY21FY23FY25
−67%485%−277%178%−488%−130%−698%−437%−908%−744%%%−300%400%FY21FY23FY25
Mar 26: null% operating margin (null pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
0.0%56%−331%−147%−650%−350%−969%−553%−1,288%−756%%%−100%0%Jun 23Sep 24Mar 26
0.0%56%−331%−147%−650%−350%−969%−553%−1,288%−756%%%−100%0%Jun 23Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Seritage Growth Properties posted a net loss of $0.03 B in the Mar 26 quarter. The full FY25 year was a loss of $0.1 B. The same quarter a year earlier lost $0.02 B. 10 of the last 12 reported quarters were loss-making.

Mar 26 profit was $−0.0 B, null year on year. On the full year, FY25 printed $−0.1 B (null).

FY25 profit $−0.1 B (null YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
Net profit
0.01−0.03−0.08−0.12−0.16$ B$−0BFY21FY23FY25
0.01−0.03−0.08−0.12−0.16$ B$−0BFY21FY23FY25
Mar 26: $−0.0 B (null YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
0.01−98.8%−0.02−99.4%−0.05−100.0%−0.08−100.6%−0.11−101.2%$ B%$0B−100%Jun 23Sep 24Mar 26
0.01−98.8%−0.02−99.4%−0.05−100.0%−0.08−100.6%−0.11−101.2%$ B%$0B−100%Jun 23Sep 24Mar 26
08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Seritage Growth Properties's cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $−0.0 B of operating cash against $−0.1 B of profit. After $0.0 B of capital spending, $−0.1 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.

FY25: operating cash of $−0.0 B against reported profit of $−0.1 B, leaving free cash of $−0.1 B after $0.0 B of capital spending.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $−0.0 B vs profit $−0.1 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 5-year window, annual resolution.
Operating cashNet profitFree cash
0.02−0.05−0.12−0.19−0.26$ B$0B$−0B$−0BFY21FY23FY25
0.02−0.05−0.12−0.19−0.26$ B$0B$−0B$−0BFY21FY23FY25
Mar 26: operating cash $−0.0 B Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)100%
0.002101.2%−0.004100.6%−0.010100.0%−0.01699.4%−0.02298.8%$ B%$0BJun 23Sep 24Mar 26
0.002101.2%−0.004100.6%−0.010100.0%−0.01699.4%−0.02298.8%$ B%$0BJun 23Sep 24Mar 26

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Seritage Growth Properties does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $0.0 B over the last 3 fiscal years.

FY25: capex $0.0 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
0.120.090.060.030.00$ B$0BFY21FY23FY25
0.120.090.060.030.00$ B$0BFY21FY23FY25
Mar 26: capex $0.0 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 12 quarters.
Capex (quarterly)Free cash
0.022−0.0080.016−0.0140.011−0.0200.005−0.0260.000−0.032$ B$ B$0B$0BJun 23Sep 24Mar 26
0.022−0.0080.016−0.0140.011−0.0200.005−0.0260.000−0.032$ B$ B$0B$0BJun 23Sep 24Mar 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

Seritage Growth Properties earns a ROE of −21% in FY25. That is up from a trough of −37% in FY24. Return on invested capital clears the cost of that capital by −22.1 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −350.0% net margin on 0.05× asset turns.

FY25 ROE is −21%, recovered from a FY24 trough of −37% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY25): −350.0% net margin × 0.05× asset turns × 1.18× balance-sheet leverage ≈ −20.6% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: −3.1% − 19.0% = a −22.1 pp spread. The 19.0% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY25: ROE −21% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 19.0% cost of capital used on this page.
the climb back from FY24's −37%
ROEROIC (annual)WACC
23%7.3%−8.8%−25%−41%%−21.2%−12.4%FY21FY23FY25
23%7.3%−8.8%−25%−41%%−21.2%−12.4%FY21FY23FY25
Mar 26: ROIC −14.3% (TTM) vs WACC 19.0% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
23%7.8%−7.7%−23%−39%%−14.3%−20.8%Jun 23Sep 24Mar 26
23%7.8%−7.7%−23%−39%%−14.3%−20.8%Jun 23Sep 24Mar 26
11 · Dividend

Dividend

Seritage Growth Properties pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.

Seritage Growth Properties does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.

12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Seritage Growth Properties carries total debt of $0.1 B against shareholder equity of $0.3 B as of Mar 26, a debt-to-equity of 0.17 — effectively unlevered. On the annual view that ratio went from 1.74 in FY21 to 0.15 in FY25. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of $0.1 B against shareholder equity of $0.3 B — a debt-to-equity of 0.17. On the annual view, debt-to-equity went from 1.74 (FY21) to 0.15 (FY25). The returns on this page are earned, not borrowed.

FY25: debt $0.1 B at 0.15× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
1.61.9×1.21.4×0.80.9×0.40.5×0.00.0×$ B×$0B0.15×FY21FY23FY25
1.61.9×1.21.4×0.80.9×0.40.5×0.00.0×$ B×$0B0.15×FY21FY23FY25
Mar 26: debt $0.1 B, debt-to-equity 0.17 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
0.61.0×0.40.8×0.30.6×0.10.3×0.00.1×$ B×$0B0.17×Jun 23Sep 24Mar 26
0.61.0×0.40.8×0.30.6×0.10.3×0.00.1×$ B×$0B0.17×Jun 23Sep 24Mar 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

11.6% of Seritage Growth Properties's tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 36.8 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 11.6% of the float is sold short, and at typical trading volumes it would take about 36.8 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
11.6%
of the tradable float
Days to cover
36.8
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Seritage Growth Properties: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

15 · Related companies · Real Estate Services
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Jones Lang LaSalle IncorporatedJLL 61.8/100Thin evidence · provisional58% evidence BREAKING OUT 21.5/35 Revenue — · PAT — · OPM change 1.1 pp 45% evidence 14.8/25 ROCE 2.8% · OPM 3.2% 76% evidence 10.9/20 P/E 14.9× · PEG — 15% evidence 14.6/20 RS sector 10.3% · RS bench -3.6% · 1Y 5.6%8 of 12 weeks ahead 100% evidence
Exact sum: 21.5 + 14.8 + 10.9 + 14.6 = 61.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
2The RMR Group Inc.RMR 60.7/100Mixed-positive evidence75% evidence ASLEEP 15.7/35 Revenue -20.4% · PAT 0% · OPM change 0.3 pp 83% evidence 14.4/25 ROCE 1.2% · OPM 4.8% 76% evidence 16.2/20 P/E 12.8× · PEG 0.46 65% evidence 14.4/20 RS sector 13.1% · RS bench -0.4% · 1Y 13%4 of 12 weeks ahead 70% evidence
Exact sum: 15.7 + 14.4 + 16.2 + 14.4 = 60.7 · Decision use: Price leads the evidence: RS versus the benchmark is -0.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
3CBRE Group, Inc.CBRE 59.6/100Mixed-positive evidence85% evidence FADING 22.9/35 Revenue 14.8% · PAT 21.9% · OPM change -0.5 pp 95% evidence 15.1/25 ROCE 2% · OPM 3.3% 76% evidence 10.1/20 P/E 30.9× · PEG 1.4 65% evidence 11.5/20 RS sector 0% · RS bench -13.1% · 1Y -15%4 of 12 weeks ahead 100% evidence
Exact sum: 22.9 + 15.1 + 10.1 + 11.5 = 59.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Star HoldingsSTHO 54.3/100Thin evidence · provisional58% evidence ASLEEP 21.2/35 Revenue 11.5% · PAT — · OPM change 21.4 pp 62% evidence 7.1/25 ROCE -1.2% · OPM -29.6% 76% evidence 11.5/20 P/E 2.3× · PEG — 15% evidence 14.5/20 RS sector 13.4% · RS bench -0.5% · 1Y 9.3%8 of 12 weeks ahead 70% evidence
Exact sum: 21.2 + 7.1 + 11.5 + 14.5 = 54.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
5IHS Holding LimitedIHS 53.8/100Mixed-positive evidence64% evidence TURNING 12.1/35 Revenue 3.7% · PAT — · OPM change -15.5 pp 62% evidence 15.2/25 ROCE 3.2% · OPM 26.8% 76% evidence 10.8/20 P/E 15.5× · PEG — 15% evidence 15.7/20 RS sector 13.8% · RS bench 0% · 1Y 23.1%0 of 12 weeks ahead 100% evidence
Exact sum: 12.1 + 15.2 + 10.8 + 15.7 = 53.8 · Decision use: Price leads the evidence: RS versus the benchmark is 0%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
6Marcus & Millichap, Inc.MMI 53.5/100Thin evidence · provisional58% evidence FADING 22.2/35 Revenue 9.7% · PAT — · OPM change 8.8 pp 62% evidence 8.4/25 ROCE -0.8% · OPM -3.4% 76% evidence 9.4/20 P/E 47.7× · PEG — 15% evidence 13.5/20 RS sector 11.2% · RS bench -2.6% · 1Y -4.5%7 of 12 weeks ahead 70% evidence
Exact sum: 22.2 + 8.4 + 9.4 + 13.5 = 53.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
7FirstService CorporationFSV 52.7/100Thin evidence · provisional58% evidence ASLEEP 20.2/35 Revenue — · PAT — · OPM change 0.4 pp 45% evidence 15.8/25 ROCE 2.9% · OPM 3.5% 76% evidence 9.7/20 P/E 40.3× · PEG — 15% evidence 7.0/20 RS sector -8.5% · RS bench -20.5% · 1Y -36%1 of 12 weeks ahead 100% evidence
Exact sum: 20.2 + 15.8 + 9.7 + 7 = 52.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
8Newmark Group, Inc.NMRK 51.3/100Thin evidence · provisional58% evidence ASLEEP 20.6/35 Revenue — · PAT — · OPM change 5.8 pp 45% evidence 13.3/25 ROCE 1.3% · OPM 3.2% 76% evidence 10.5/20 P/E 18.7× · PEG — 15% evidence 6.9/20 RS sector -7.5% · RS bench -19.6% · 1Y -27.5%2 of 12 weeks ahead 100% evidence
Exact sum: 20.6 + 13.3 + 10.5 + 6.9 = 51.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
9CoStar Group, Inc.CSGP 51.2/100Thin evidence · provisional58% evidence BASING 22.9/35 Revenue — · PAT — · OPM change 6.2 pp 45% evidence 12.3/25 ROCE 0.8% · OPM 0.3% 76% evidence 9.3/20 P/E 149.1× · PEG — 15% evidence 6.7/20 RS sector -35% · RS bench -44.7% · 1Y -66.6%0 of 12 weeks ahead 100% evidence
Exact sum: 22.9 + 12.3 + 9.3 + 6.7 = 51.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
10Colliers International Group Inc.CIGI 47.5/100Thin evidence · provisional58% evidence ASLEEP 17.5/35 Revenue — · PAT — · OPM change -0.1 pp 45% evidence 14.1/25 ROCE 1.8% · OPM 2.7% 76% evidence 9.6/20 P/E 44.6× · PEG — 15% evidence 6.3/20 RS sector -20.4% · RS bench -31.4% · 1Y -45.5%3 of 12 weeks ahead 100% evidence
Exact sum: 17.5 + 14.1 + 9.6 + 6.3 = 47.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
11Transcontinental Realty Investors, Inc.TCI 46.7/100Mixed-negative evidence75% evidence TURNING 14.2/35 Revenue 2.1% · PAT 0% · OPM change -10.6 pp 83% evidence 9.8/25 ROCE -0.2% · OPM -15.9% 76% evidence 14.0/20 P/E 32× · PEG 0.54 65% evidence 8.7/20 RS sector -0.8% · RS bench -14.1% · 1Y -13.8%4 of 12 weeks ahead 70% evidence
Exact sum: 14.2 + 9.8 + 14 + 8.7 = 46.7 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
12Cushman & Wakefield LimitedCWK 45.8/100Mixed-negative evidence71% evidence ASLEEP 18.0/35 Revenue 10.4% · PAT -53.8% · OPM change 0.3 pp 83% evidence 11.8/25 ROCE 1.1% · OPM 2.3% 76% evidence 9.9/20 P/E 38.3× · PEG — 15% evidence 6.1/20 RS sector -8.1% · RS bench -20.2% · 1Y -25.5%3 of 12 weeks ahead 100% evidence
Exact sum: 18 + 11.8 + 9.9 + 6.1 = 45.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13American Realty Investors, Inc.ARL 45.6/100Thin evidence · provisional58% evidence ASLEEP 14.9/35 Revenue 4.2% · PAT — · OPM change -11 pp 62% evidence 9.1/25 ROCE -0.2% · OPM -17.8% 76% evidence 10.3/20 P/E 20.3× · PEG — 15% evidence 11.3/20 RS sector 4.1% · RS bench -9.3% · 1Y -5.3%7 of 12 weeks ahead 70% evidence
Exact sum: 14.9 + 9.1 + 10.3 + 11.3 = 45.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
14RE/MAX Holdings, Inc.RMAX 43.1/100Mixed-negative evidence74% evidence 9.2/35 Revenue -5% · PAT -90% · OPM change -18.3 pp 62% evidence 7.5/25 ROCE -1.8% · OPM -11.1% 76% evidence 6.6/20 P/E 576× · PEG 1.66 65% evidence 19.8/20 RS sector 42.8% · RS bench 31.2% · 1Y 31.2%7 of 9 weeks ahead 100% evidence
Exact sum: 9.2 + 7.5 + 6.6 + 19.8 = 43.1 · Decision use: Price leads the evidence: RS versus the benchmark is 31.2%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
15The Real Brokerage Inc.REAX 42.9/100Thin evidence · provisional55% evidence ASLEEP 24.0/35 Revenue 46.8% · PAT — · OPM change 0.8 pp 62% evidence 5.2/25 ROCE -7% · OPM -0.7% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 3.7/20 RS sector -36.7% · RS bench -46% · 1Y -66.3%5 of 12 weeks ahead 70% evidence
Exact sum: 24 + 5.2 + 10 + 3.7 = 42.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
16FRP Holdings, Inc.FRPH 38.7/100Mixed-negative evidence65% evidence ASLEEP 11.4/35 Revenue 4.8% · PAT -85.7% · OPM change -17.8 pp 83% evidence 11.1/25 ROCE 0.1% · OPM 4.8% 76% evidence 8.7/20 P/E 547× · PEG — 15% evidence 7.5/20 RS sector -3.6% · RS bench -15.9% · 1Y -14.2%0 of 12 weeks ahead 70% evidence
Exact sum: 11.4 + 11.1 + 8.7 + 7.5 = 38.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Seaport Entertainment Group Inc.SEG 38.6/100Thin evidence · provisional55% evidence ASLEEP 12.1/35 Revenue 13.4% · PAT — · OPM change -130.3 pp 62% evidence 3.8/25 ROCE -7% · OPM -333.8% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 12.7/20 RS sector 10.1% · RS bench -3.4% · 1Y 0%8 of 12 weeks ahead 70% evidence
Exact sum: 12.1 + 3.8 + 10 + 12.7 = 38.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
18AGNT, IncAGNT 38.3/100Thin evidence · provisional58% evidence ASLEEP 18.6/35 Revenue 5.3% · PAT — · OPM change 0.2 pp 62% evidence 7.5/25 ROCE -3.8% · OPM -0.9% 76% evidence 8.8/20 P/E 406× · PEG — 15% evidence 3.4/20 RS sector -43.7% · RS bench -52% · 1Y -65.7%0 of 12 weeks ahead 70% evidence
Exact sum: 18.6 + 7.5 + 8.8 + 3.4 = 38.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
19Compass, Inc.COMP 37.5/100Mixed-negative evidence64% evidence ASLEEP 14.9/35 Revenue 40.1% · PAT — · OPM change -9 pp 62% evidence 4.2/25 ROCE -8.9% · OPM -13% 76% evidence 9.0/20 P/E 365.5× · PEG — 15% evidence 9.4/20 RS sector 9.4% · RS bench -4.5% · 1Y 7.2%11 of 12 weeks ahead 100% evidence
Exact sum: 14.9 + 4.2 + 9 + 9.4 = 37.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Maui Land & Pineapple Company, Inc.MLP 36.0/100Mixed-negative evidence65% evidence ASLEEP 11.4/35 Revenue 20% · PAT -500% · OPM change -28.5 pp 83% evidence 4.9/25 ROCE -5.5% · OPM -59.2% 76% evidence 9.1/20 P/E 239.2× · PEG — 15% evidence 10.6/20 RS sector 2.9% · RS bench -10.1% · 1Y -15.8%3 of 12 weeks ahead 70% evidence
Exact sum: 11.4 + 4.9 + 9.1 + 10.6 = 36 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21Douglas Elliman Inc.DOUG 32.3/100Thin evidence · provisional58% evidence ASLEEP 9.7/35 Revenue -5.3% · PAT — · OPM change -6.1 pp 62% evidence 6.3/25 ROCE -4.8% · OPM -8.2% 76% evidence 11.1/20 P/E 13.9× · PEG — 15% evidence 5.2/20 RS sector -16% · RS bench -27.6% · 1Y -43.1%2 of 12 weeks ahead 70% evidence
Exact sum: 9.7 + 6.3 + 11.1 + 5.2 = 32.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
22Seritage Growth Propertiesthis pageSRG 31.0/100Thin evidence · provisional51% evidence ASLEEP 9.2/35 Revenue 0% · PAT — · OPM change -635.5 pp 62% evidence 7.3/25 ROCE -4.2% · OPM — 61% evidence 10.0/20 P/E — · PEG — 0% evidence 4.5/20 RS sector -33.3% · RS bench -42.5% · 1Y -54.4%0 of 12 weeks ahead 70% evidence
Exact sum: 9.2 + 7.3 + 10 + 4.5 = 31 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
23Opendoor Technologies Inc.OPEN 21.9/100Adverse evidence61% evidence ASLEEP 7.9/35 Revenue -23.2% · PAT — · OPM change -17.2 pp 62% evidence 4.0/25 ROCE -7.5% · OPM -22.1% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 0.0/20 RS sector -49.1% · RS bench -56.4% · 1Y -73.2%0 of 12 weeks ahead 100% evidence
Exact sum: 7.9 + 4 + 10 + 0 = 21.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24Comstock Holding Companies, Inc.CHCI 66.9/100Thin evidence · provisional47% evidence BREAKING OUT 22.3/35 Revenue 24.1% · PAT 13.3% · OPM change — 45% evidence 13.6/25 ROCE — · OPM — 15% evidence 14.1/20 P/E 11.4× · PEG 0.83 65% evidence 16.9/20 RS sector 48.6% · RS bench 31% · 1Y 30.1%5 of 12 weeks ahead 70% evidence
Exact sum: 22.3 + 13.6 + 14.1 + 16.9 = 66.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
25Rafael Holdings, Inc.RFL 54.1/100Thin evidence · provisional24% evidence 16.3/35 Revenue — · PAT — · OPM change — 8% evidence 10.9/25 ROCE — · OPM — 15% evidence 10.6/20 P/E 18.1× · PEG — 15% evidence 16.3/20 RS sector 32% · RS bench 20.6% · 1Y 23.5%6 of 6 weeks ahead to 2026-08-07 70% evidence
Exact sum: 16.3 + 10.9 + 10.6 + 16.3 = 54.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
26New England Realty Associates Limited PartnershipNEN 43.6/100Thin evidence · provisional48% evidence ASLEEP 11.7/35 Revenue 14.8% · PAT -112.5% · OPM change -23.9 pp 83% evidence 11.9/25 ROCE 0.4% · OPM 6.2% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y -28%0 of 11 weeks ahead 0% evidence
Exact sum: 11.7 + 11.9 + 10 + 10 = 43.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
27Hotel101 Global Holdings Corp.HBNB 42.7/100Thin evidence · provisional29% evidence ASLEEP 18.3/35 Revenue — · PAT — · OPM change — 9% evidence 8.9/25 ROCE -1.7% · OPM — 46% evidence 10.0/20 P/E — · PEG — 0% evidence 5.5/20 RS sector -15.5% · RS bench -26.4% · 1Y 67.9%0 of 12 weeks ahead 70% evidence
Exact sum: 18.3 + 8.9 + 10 + 5.5 = 42.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Seritage Growth Properties's stock price today?

Seritage Growth Properties trades at $1.9, −54.4% over the past year. The company is valued at $0.0 B. The stock sits at the very bottom of its 52-week range ($2–$4), −32.1% versus its 200-day average. Against the S&P 500 it has been behind on a trailing-13-week view for 44 weeks. — as of 21 September 2026.

What were Seritage Growth Properties's latest quarterly results?

Seritage Growth Properties reported revenue of $0.0 B and a net loss of $0.0 B for the Mar 26 quarter. Earnings per share were $−0.56. — as of 21 September 2026.

What is Seritage Growth Properties's revenue?

Seritage Growth Properties reported revenue of $0.0 B in the Mar 26 quarter. For the full FY25 fiscal year, revenue was $0.0 B (+0.0%). Over the last 4 years revenue compounded at −36.1% a year. — as of 21 September 2026.

What is Seritage Growth Properties's profit?

Seritage Growth Properties earned $−0.0 B of net profit in the Mar 26 quarter. Full-year FY25 profit was $−0.1 B. — as of 21 September 2026.

What is Seritage Growth Properties's market cap?

Seritage Growth Properties's market capitalisation is $0.0 B at a stock price of $1.9. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 21 September 2026.

Does Seritage Growth Properties pay a dividend?

No — Seritage Growth Properties has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 21 September 2026.

How is Seritage Growth Properties performing?

Seritage Growth Properties's latest readings are below. Against the S&P 500 it has been behind on a trailing-13-week view for 44 weeks. This describes what the data did, not a rating. — as of 21 September 2026.

Is Seritage Growth Properties beating the market?

Not lately — on a trailing-13-week view Seritage Growth Properties is currently behind the S&P 500 (44 weeks and counting; last ahead the week of 2025-11-14), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.2 years the stock moved −39% against the S&P 500's +22% — behind the index over the full window. — as of 21 September 2026.

Will Seritage Growth Properties's stock price go up?

This page publishes no price forecast for Seritage Growth Properties. What it measures instead: the stock price is $1.9. Direction is not something this site claims to know. — as of 21 September 2026.

Is the market betting against Seritage Growth Properties?

Yes — short interest is 11.6% of Seritage Growth Properties's tradable float, about 36.8 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 21 September 2026.

Does Seritage Growth Properties have too much debt?

No — Seritage Growth Properties's debt-to-equity is 0.17. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. The returns on this page are earned, not borrowed — as of 21 September 2026.

What is Seritage Growth Properties's capex?

Seritage Growth Properties spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 21 September 2026.

What is Seritage Growth Properties's cash flow?

Seritage Growth Properties consumed $0.0 B of operating cash in FY25 — cash flowed out rather than in (free cash flow: $−0.1 B). Reported profit that year was $−0.1 B, so operating cash ran ahead of profit. — as of 21 September 2026.

Where is Seritage Growth Properties in its business cycle?

Seritage Growth Properties's FY25 operating margin was −300.0%, against a 5-year band of −850.0%–−125.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 21 September 2026.

What could break the Seritage Growth Properties story?

Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 21 September 2026.

Is Seritage Growth Properties a stock worth studying right now?

This is not investment advice. The machine read: Seritage Growth Properties's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 21 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-21. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI